Saba Capital Management Amends 13D Filing for New Germany Fund
Ticker: GF · Form: SC 13D/A · Filed: Nov 21, 2024 · CIK: 858706
Sentiment: neutral
Topics: activist-filing, shareholder-activity, sec-filing
TL;DR
Saba Capital updated its stake in New Germany Fund. Watch for potential moves.
AI Summary
Saba Capital Management, L.P. filed an amendment (No. 2) to its Schedule 13D on November 21, 2024, regarding its holdings in The New Germany Fund, Inc. The filing indicates changes in beneficial ownership of the common shares. Saba Capital Management GP, LLC and Boaz R. Weinstein are listed as group members.
Why It Matters
This amendment signals potential shifts in significant shareholder positions and strategies concerning The New Germany Fund, Inc., which could impact its stock performance and corporate governance.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate active engagement by significant shareholders, which can lead to volatility or strategic changes in the target company.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filing entity
- The New Germany Fund, Inc. (company) — Subject company
- Boaz R. Weinstein (person) — Group member
- Saba Capital Management GP, LLC (company) — Group member
- Michael D'Angelo (person) — Authorized contact person
FAQ
What specific changes in beneficial ownership are detailed in this amendment?
The filing is an amendment (No. 2) to Schedule 13D, indicating changes in beneficial ownership, but the specific details of these changes are not provided in the header information.
When was this amendment filed with the SEC?
This amendment was filed on November 21, 2024.
Who is the subject company of this filing?
The subject company is The New Germany Fund, Inc.
Who is filing this amendment?
Saba Capital Management, L.P. is filing this amendment.
What is the CUSIP number for the securities in question?
The CUSIP number for the Common Shares of The New Germany Fund, Inc. is 644465106.
Filing Stats: 1,383 words · 6 min read · ~5 pages · Grade level 10.9 · Accepted 2024-11-21 16:06:17
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
- $10,517,438 — ported herein. A total of approximately $10,517,438 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 70KB
- 0001062993-24-019491.txt ( ) — 71KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: November 21, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 644465106 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital from the filing of the Schedule 13D/A on 10/15/24 to November 19, 2024, the date of the event which required filing of this Schedule 13D/A. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 10/15/2024 Buy 500 8.68 10/16/2024 Buy 24,721 8.70 10/17/2024 Buy 9,092 8.72 10/22/2024 Buy 2,148 8.65 10/23/2024 Buy 5,941 8.61 10/25/2024 Buy 11,488 8.67 10/29/2024 Buy 49,130 8.65 11/7/2024 Buy 3,192 8.42 11/8/2024 Buy 14,273 8.36 11/11/2024 Buy 4,720 8.48 11/12/2024 Buy 8,941 8.30 11/13/2024 Buy 4,263 8.24 11/14/2024 Buy 3,154 8.28 11/15/2024 Buy 4,771 8.24 11/19/2024 Buy 49,663 8.10